<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="752">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05151367</url>
  </required_header>
  <id_info>
    <org_study_id>AAAT1572</org_study_id>
    <secondary_id>1R21CA253604-01</secondary_id>
    <nct_id>NCT05151367</nct_id>
  </id_info>
  <brief_title>SMS HPV Vaccine Reminders</brief_title>
  <acronym>SEARCH</acronym>
  <official_title>SEARCH: Short Message Service (SMS) Electronic Adolescent Reminders for Completion of HPV Vaccination - Uganda: Pilot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Makerere University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will take place at health centres and their affiliated schools and community&#xD;
      immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the&#xD;
      Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can&#xD;
      be used in populations with low literacy, families can opt to receive automated phone call&#xD;
      reminders instead. The investigators will pilot assess the impact of vaccine reminders on&#xD;
      human papillomavirus (HPV) vaccination. Caregivers of preteens/adolescents will be randomized&#xD;
      and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). As&#xD;
      this is a feasibility trial, the investigators expect to measure effect size but not&#xD;
      necessarily achieve statistical significance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cervical cancer is the leading female cancer in Uganda. Many women are diagnosed with&#xD;
      late-stage disease, and 80% of women die within 5 years of diagnosis, making primary&#xD;
      prevention critical. HPV is the principal cause of cervical cancer, making vaccination the&#xD;
      single most important primary preventive measure. The national HPV vaccination program in&#xD;
      Uganda began in November 2015 and focuses solely on preteen/adolescent girls. Two strategies&#xD;
      have been adopted for the multi-dose series: 1) school-based and 2) community-based. However,&#xD;
      in Kampala, only 29% of girls receive both needed doses. Reasons for undervaccination include&#xD;
      school absenteeism on special vaccination days for those receiving vaccination as part of a&#xD;
      school program, failing to remember to come to a health facility for a needed dose for those&#xD;
      being vaccinated in the community, and lack of knowledge regarding HPV and the vaccines&#xD;
      including vaccine misperceptions. While research regarding the use of text message vaccine&#xD;
      reminders is strong in the U.S., their use has not yet been demonstrated in a&#xD;
      preteen/adolescent population in Sub-Saharan Africa and other low and middle income countries&#xD;
      (LMICs). According to the World Bank, currently 89.9% of urban households in Uganda have a&#xD;
      cell phone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Receipt of Next HPV Vaccine Dose</measure>
    <time_frame>Up to 6 months from randomization</time_frame>
    <description>Timeliness of vaccination (time to event) will be measured.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">154</enrollment>
  <condition>Human Papillomavirus Vaccination</condition>
  <arm_group>
    <arm_group_label>Text message reminders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Text message reminders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No reminders</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Text message reminder</intervention_name>
    <description>Receipt of text messages notifying when the next HPV vaccine dose is due (either first or second)</description>
    <arm_group_label>Text message reminders</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be a parenting adult of an adolescent girl aged 10-14 years&#xD;
&#xD;
          -  Reside in Kampala and/or the surrounding districts&#xD;
&#xD;
          -  Speak English or Luganda&#xD;
&#xD;
          -  Have a cell phone with text messaging capability&#xD;
&#xD;
          -  Must have ability to consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Parenting adult speaks other language than English or Luganda only&#xD;
&#xD;
          -  Parenting adult already enrolled in the study for another child&#xD;
&#xD;
          -  Participation in pretesting activities&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melissa S. Stockwell, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa S. Stockwell, MD, MPH</last_name>
    <phone>212-342-5732</phone>
    <email>mss2112@cumc.columbia.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ashley Stephens, MD</last_name>
    <phone>212-305-6227</phone>
    <email>abs2258@cumc.columbia.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Melissa S. Stockwell, MD, MPH</last_name>
      <phone>212-342-5732</phone>
      <email>mss2112@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Betsy Pfeffer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ashley Stephens, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Makerere University/Mulago Hospital</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Sabrina Bakeera- Kitaka, MBChB, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sabrina Bakeera- Kitaka, MBChB, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Rujumba, SWSA, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolette Nabukeera-Barungi, MBChB, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juliet Babirye, MD, MPH, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ezekiel Mupere, MBChB, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Uganda</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>November 26, 2021</last_update_submitted>
  <last_update_submitted_qc>November 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Melissa Stockwell</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics and Population and Family Health</investigator_title>
  </responsible_party>
  <keyword>Human papillomavirus</keyword>
  <keyword>Vaccination</keyword>
  <keyword>Text message</keyword>
  <keyword>SMS</keyword>
  <keyword>mHealth</keyword>
  <keyword>Reminder</keyword>
  <keyword>Uganda</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

